Abbvie (ABBV) PT Raised to $128 at Mizuho Securities

May 3, 2021 6:38 AM

Mizuho Securities analyst Vamil Divan raised the price target on Abbvie (NYSE: ABBV) to $128.00 (from $126.00) while maintaining a Buy rating.

No results found